BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27765277)

  • 21. Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
    Susini T; Olivieri S; Molino C; Castiglione F; Tavella K; Viligiardi R
    J Womens Health (Larchmt); 2010 Jan; 19(1):169-74. PubMed ID: 20088673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
    Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian carcinoma metastatic to the breast and axillary node.
    Duda RB; August CZ; Schink JC
    Surgery; 1991 Sep; 110(3):552-6. PubMed ID: 1887382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary nodal metastasis in ovarian cancer: a report of three cases and review of literature.
    Zuhdy M; Alghandour R; Abdelazeem G; Saleh GA; Saleh MM; Hamdy M; Hamdy O
    J Egypt Natl Canc Inst; 2019 Dec; 31(1):9. PubMed ID: 32372131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer.
    Mustonen P; Farin P; Kosunen O
    Ann Chir Gynaecol; 1990; 79(1):15-8. PubMed ID: 2192685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sentinel lymphatic node biopsy for breast cancer in practice].
    Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
    Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy.
    Nori J; Bazzocchi M; Boeri C; Vanzi E; Nori Bufalini F; Mangialavori G; Distante V; Masi A; Simoncini R; Londero V
    Radiol Med; 2005 Apr; 109(4):330-44. PubMed ID: 15883518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
    Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
    J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False negative results of preoperative axillary ultrasound in patients with invasive breast cancer: correlations with clinicopathologic findings.
    Choi JS; Kim MJ; Moon HJ; Kim EK; Yoon JH
    Ultrasound Med Biol; 2012 Nov; 38(11):1881-6. PubMed ID: 22975037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.
    Murray AD; Staff RT; Redpath TW; Gilbert FJ; Ah-See AK; Brookes JA; Miller ID; Payne S
    Br J Radiol; 2002 Mar; 75(891):220-8. PubMed ID: 11932214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult breast carcinoma presenting with axillary lymph node metastases.
    Medina-Franco H; Urist MM
    Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian carcinoma initially presenting as metastatic axillary lymphadenopathy.
    Hockstein S; Keh P; Lurain JR; Fishman DA
    Gynecol Oncol; 1997 Jun; 65(3):543-7. PubMed ID: 9190992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic appearance of axillary lymph node calcification in patients with metastatic ovarian carcinoma.
    Singer C; Blankstein E; Koenigsberg T; Mercado C; Pile-Spellman E; Smith SJ
    AJR Am J Roentgenol; 2001 Jun; 176(6):1437-40. PubMed ID: 11373209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinics in diagnostic imaging (125). Diagnosis: Suspicious right breast carcinoma with axillary node metastases.
    Padungchaichote W; Kongmebhol P; Muttarak M
    Singapore Med J; 2008 Dec; 49(12):1062-5; quiz 1066. PubMed ID: 19122965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.